Case-Based Learning: Evaluating Recurrent Fever With Multiple Possible Systemic Triggers

Abstract

Recurrent fever is a challenging clinical presentation with a broad differential diagnosis encompassing infectious, autoimmune, autoinflammatory, and neoplastic etiologies. This review article explores the systematic evaluation of recurrent fever using a case-based learning approach, emphasizing the importance of integrating clinical reasoning, evidence-based strategies, and up-to-date guideline recommendations. Through an examination of epidemiology, pathophysiology, risk factors, clinical features, diagnostic algorithms, and current management strategies, this article aims to provide healthcare professionals with a comprehensive, practical framework for approaching recurrent fever with multiple possible systemic triggers.

Introduction

Recurrent fever, defined as the repeated occurrence of elevated body temperature separated by afebrile periods, poses a diagnostic challenge in clinical practice. Physicians are often confronted with patients presenting persistent febrile episodes with no obvious cause, requiring careful consideration of a wide array of potential systemic triggers. This complexity necessitates a structured approach, guided by current evidence, clinical guidelines, and a nuanced understanding of underlying pathobiology. The case-based learning methodology not only aids clinical reasoning but also enhances the practical application of theoretical knowledge in the diagnostic and therapeutic evaluation of such patients.

Epidemiology / Disease Burden

The prevalence of recurrent fever varies globally and is influenced by geographic, demographic, and socio-economic factors. In developed countries, the majority of cases are attributed to autoimmune, autoinflammatory, and neoplastic etiologies, while infectious causes predominate in resource-limited settings. Periodic fever syndromes, such as Familial Mediterranean Fever (FMF) and Periodic Fever, Aphthous Stomatitis, Pharyngitis, and Adenitis (PFAPA), are increasingly recognized in pediatric populations. However, a significant proportion of adult cases remain idiopathic despite extensive evaluation, underscoring the persistent burden and diagnostic complexity of recurrent fever in clinical practice. Recent multicenter data suggest that up to 10% of patients referred to tertiary care for fever of unknown origin (FUO) exhibit recurrent patterns, with substantial implications for healthcare utilization, patient quality of life, and morbidity risk.

Pathophysiology

The pathophysiology of recurrent fever is multifactorial, involving dysregulated immune responses, defective pathogen recognition, and altered cytokine production. In infectious etiologies, intermittent pathogen proliferation or reactivation triggers episodic immune activation. Autoimmune and autoinflammatory disorders, such as systemic lupus erythematosus (SLE) and FMF, involve aberrant activation of innate or adaptive immunity, leading to periodic inflammatory flares. Malignancies, particularly lymphoproliferative disorders, may cause paraneoplastic fever through cytokine-mediated mechanisms. Importantly, genetic predispositions, such as mutations in MEFV (FMF) or NLRP3 (Cryopyrin-Associated Periodic Syndromes), have elucidated key molecular pathways, including IL-1β and TNF-α signaling, driving recurrent febrile responses. This mechanistic understanding informs targeted therapeutic strategies and guides the diagnostic workup.

Risk Factors

Risk factors for recurrent fever depend on the underlying etiology. Family history of periodic fever syndromes or autoimmune diseases increases susceptibility, particularly in pediatric populations. Immunocompromised states, including post-transplant status, HIV infection, and iatrogenic immunosuppression, predispose patients to recurrent infectious triggers. Environmental exposures, travel history, and occupational risks (e.g., healthcare, laboratory work, or agriculture) are also pertinent. Genetic factors, such as mutations associated with monogenic autoinflammatory syndromes, play a critical role in select patient cohorts. Additionally, chronic inflammatory conditions and malignancies represent important risk factors, necessitating vigilance in at-risk populations.

Clinical Features

Recurrent fever typically presents with stereotypical fever episodes, often accompanied by constitutional symptoms such as malaise, myalgia, and fatigue. Disease-specific features provide diagnostic clues: FMF may present with serositis and erysipelas-like erythema; PFAPA is characterized by aphthous ulcers, pharyngitis, and cervical adenitis. Autoimmune diseases may exhibit rash, arthralgia, or organ-specific manifestations. Infectious causes often reveal focal symptoms or epidemiological links. The temporal pattern, duration, and associated symptoms of each fever episode are critical; for example, cyclic neutropenia exhibits predictable febrile cycles, while neoplastic fevers may be less periodic. Thorough history, physical examination, and review of systems are essential to narrow the differential diagnosis.

Diagnosis

Diagnostic evaluation begins with a detailed patient history and comprehensive physical exam. Initial laboratory investigations include complete blood count, inflammatory markers (CRP, ESR), liver and renal function tests, and blood cultures. Serial testing during and between fever episodes can yield valuable diagnostic information. Autoimmune and autoinflammatory panels, infectious serologies, and imaging (e.g., chest radiography, abdominal ultrasound, or CT) are tailored based on clinical suspicion. Molecular diagnostics and genetic testing are indicated in selected cases, particularly in young patients with early-onset or familial patterns. Bone marrow biopsy or advanced imaging may be necessary if malignancy is suspected. A structured, stepwise approach, guided by current clinical guidelines, avoids unnecessary investigations and expedites diagnosis.

Treatment & Management

Management of recurrent fever is etiology-specific and should be individualized based on severity, comorbidities, and patient preferences. Infectious causes require targeted antimicrobial therapy, while autoimmune and autoinflammatory disorders may benefit from immunosuppressive or biologic agents. For example, colchicine is first-line for FMF, while IL-1 inhibitors are effective in cryopyrinopathies. Supportive care, including antipyretics and hydration, remains important. Patient education, regular follow-up, and multidisciplinary collaboration are critical for optimizing outcomes and monitoring for complications. In idiopathic cases, empirical therapy should be avoided unless clinically justified, and patients should be periodically reassessed for evolving features suggestive of a specific diagnosis.

Recent Advances / Emerging Therapies

Recent advances in molecular diagnostics, including next-generation sequencing and cytokine profiling, have improved the identification of monogenic periodic fever syndromes and clarified mechanistic pathways. Targeted biologic therapies, such as IL-1 and IL-6 inhibitors, have revolutionized the management of refractory autoinflammatory conditions. Janus kinase (JAK) inhibitors and novel small molecules are emerging as promising options in select patient populations. Artificial intelligence and machine learning algorithms are also being explored for pattern recognition and risk stratification in patients with recurrent fever. Ongoing clinical trials and registry data continue to inform best practices and refine treatment algorithms.

Guideline Recommendations

Current clinical guidelines, including those from the European League Against Rheumatism (EULAR) and the American College of Rheumatology (ACR), emphasize a systematic, evidence-based approach to recurrent fever. Key recommendations include early recognition of red flag features, judicious use of laboratory and genetic testing, and prompt initiation of targeted therapy in confirmed cases. Multidisciplinary care and patient-centered communication are central to effective management. Guidelines also underscore the importance of periodic re-evaluation in undiagnosed cases and encourage participation in clinical research to advance the understanding of recurrent fever syndromes.

Conclusion

Recurrent fever with multiple possible systemic triggers represents a complex diagnostic and therapeutic challenge in clinical practice. A methodical, evidence-based approach grounded in up-to-date research, clinical guidelines, and mechanism-based reasoning enables accurate diagnosis, optimal management, and improved patient outcomes. Advances in molecular diagnostics and targeted therapies hold promise for further refining care in this evolving field. Ongoing education, multidisciplinary collaboration, and research participation remain essential for addressing the unmet needs of patients with recurrent fever.